16 - Prospective Clinical Trial of Mycophenolate Mofetil (MMF) De-Escalation in Allogeneic Hematopoietic Cell Transplantation (HCT) for Primary Immunodeficiency (PID): MMF Is Dispensable in Reduced-Intensity Conditioning, Posttransplantation Cyclophosphamide(PTCy)-Based HCT
- Resource Type
- Abstract
- Authors
- Dimitrova, Dimana; Napier, Scott; Sponaugle, Jennifer; Stokes, Anita; Hyder, Mustafa; Uzel, Gulbu; Notarangelo, Luigi D.; Freeman, Alexandra F.; Bergerson, Jenna R.E.; Holland, Steven M.; Roschewski, Mark; Melani, Christopher; Cohen, Jeffrey I.; Lisco, Andrea; Sereti, Irini; Zerbe, Christa; Ombrello, Amanda K.; Stone, Deborah; Cuellar-Rodriguez, Jennifer; Gea-Banacloche, Juan; Parta, Mark; Wilder, Jennifer; Chai, Amy; Fowler, Daniel H.; Gress, Ronald E; Kanakry, Christopher G.; Kanakry, Jennifer A.
- Source
- In Transplantation and Cellular Therapy March 2022 28(3) Supplement:S14-S16
- Subject
- Language
- ISSN
- 2666-6367